BCM
ZLAB icon

Bayesian Capital Management’s Zai Lab ZLAB Stock Holding History

Bayesian Capital Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,469
Closed -$405K – 1019
2024
Q4 		$405K Buy
+15,469
New +$429K 0.05% 418
2022
Q3 		– Sell
-9,100
Closed -$316K – 1062
2022
Q2 		$316K Buy
+9,100
New +$321K 0.06% 464

Other funds holding ZLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bayesian Capital Management's ZLAB Position: Q1 2025 in Review

Bayesian Capital Management sold out of Zai Lab (ZLAB) in Q1 2025, closing a stake of 15,469 shares — an estimated $405K sold.

Bayesian Capital Management first reported a position in ZLAB in Q2 2022 and held it in 2 quarters. The position peaked at $405K in Q4 2024. 160 funds tracked by Wall St. Rank hold ZLAB as of Q1 2025.

  • Bayesian Capital Management reported no remaining Zai Lab position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 15,469 Zai Lab shares in Q1 2025, an estimated $405K.
  • Bayesian Capital Management first reported a position in Zai Lab in Q2 2022 and held it in 2 quarters.
  • Bayesian Capital Management's Zai Lab position peaked at $405K in Q4 2024.
  • 160 funds tracked by Wall St. Rank held Zai Lab as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.